Law firm Paul Hastings announced that the firm represented HIG Capital, an investor in middle-market companies, and its credit affiliate Bayside Finance as a lender in connection with a $65 million term loan facility for specialty pharmaceutical company Acella Pharmaceuticals, LLC and its affiliates, Neuvosyn Laboratories, LLC and Avion Pharmaceuticals, LLC.

Finance and restructuring partner Chris Molen led the Paul Hastings team, which also included partner Paul Quinn and associates Chadwick Werner, Paul Puckett and Maria Merritt.